Am J Transplant, Volume 20, Suppl 3 Archives - Page 200 of 223 - ATC Abstracts

2020 American Transplant Congress
Preformed Anti-HLA Donor-Specific Antibodies Immunological Risk Assessment: The Importance of HLA Antibody Locus-Specificity
V. Jucaud¹, A. Babu², D. Briggs³, N. Krishnan⁴, D. Mitchell⁵, M. Everly¹
¹Terasaki Research Institute, Los Angeles, CA, ²University Hospitals Coventry and Warwickshire, Coventry, United Kingdom, ³NHS Blood and Transplant, Birmingham, United Kingdom, ⁴University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom, ⁵University of Warwick Medical School, Coventry, United Kingdom
*Purpose: The screening of preformed donor-specific HLA antibodies (pfDSA) by single antigen bead assays has increased the complexity of pre-transplant patient risk stratification. We evaluated…
2020 American Transplant Congress
Paired-Donor Kidney Exchange Has Comparable Early Graft Function to Directed Living Donor
E. McCracken, A. Sites, B. Rawashdeh, A. Nishio-Lucar, A. Agarwal
Transplant Surgery, University of Virginia, Charlottesville, VA
*Purpose: Living kidney donation in the United States is associated with improved graft and patient survival. However, there is minimal data on graft function in…
2020 American Transplant Congress
Impact of Enhanced Recovery after Surgery Protocols on Robotic Living Kidney Donor Outcomes: A Single Center Experience
B. Ruch, A. Sharma, J. Amery, C. Bhati, A. Khan, A. Cotterell, M. Scott, M. Levy
Virginia Commonwealth University, Richmond, VA
*Purpose: Traditional management of living donor nephrectomies includes intraoperative volume loading to maintain renal perfusion and urine output. Recently our center initiated fluid restriction as…
2020 American Transplant Congress
Characterization of Use and Safety of Non-Insulin Agents for Management of Post-Transplant Diabetes Mellitus in the Kidney Transplant Population
M. Norris¹, J. Trofe-Clark¹, C. Sammons¹, N. Casciello¹, S. Cardillo², D. Sawinski³, R. D. Bloom³, G. Malat¹
¹Pharmacy, Hosp of Univ of Pennsylvania, Philadelphia, PA, ²Endocrine Div, Univ of Pennsylvania, Philadelphia, PA, ³Renal Div, Univ of Pennsylvania, Philadelphia, PA
*Purpose: Newer, non-insulin agents appear to have significant cardiovascular benefits. However, use of these agents for diabetes (DM) management in kidney transplant recipients (KTR) has…
2020 American Transplant Congress
Incidence and Risks Factors of Kidney Allograft Loss Due to BK Virus in Pediatric Population: UNOS Data Set
H. Patel¹, K. Agrawal¹, A. Pawar¹, N. Rodig², N. Agrawal¹, F. Cardarelli¹
¹Transplant Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, ²Nephrology (Medicine), Boston Children's Hospital, Boston, MA
*Purpose: BK virus infection can lead to graft dysfunction and loss in kidney transplant patients. Incidence and prevalence of BK Viremia (BKV) and BK Virus…
2020 American Transplant Congress
Comparison of Reduced-Dose and Labeled-Dose Belatacept Conversion with Immediate or Early Tacrolimus Withdrawal in Kidney Transplant Recipients without Maintenance Corticosteroids
H. Kuzaro¹, A. R. Shields², M. Cuffy², E. S. Woodle¹, K. Pembaur², S. Safdar², S. Huang², G. Krisko², S. Raabe², R. Parks², J. Kremer²
¹U Cincinnati, Cincinnati, OH, ²The Christ Hospital, Cincinnati, OH
*Purpose: A primary reason for conversion from tacrolimus (TAC) to belatacept (BELA) is to avoid nephrotoxicity. Previous published experiences with BELA-conversion regimens have shown increased…
2020 American Transplant Congress
Readmission Outcomes of Bariatric Surgery in Liver Transplant Recipients
R. A. Choudhury¹, D. Yoeli¹, H. Yaffe¹, H. B. Moore¹, G. Hoeltzel², A. Schulick¹, P. L. Abt³, K. Dumon⁴, K. D. Conzen¹, J. J. Pomposelli¹, E. A. Pomfret¹, T. L. Nydam¹
¹Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, ²Thomas Jefferson University Hospital, Philadelphia, PA, ³Department of Surgery- Division of Transplantation Surgery, University of Pennsylvania Hospital, Philadelphia, PA, ⁴Department of Surgery, University of Pennsylvania Hospital, Philadelphia, PA
*Purpose: Bariatric surgery has increasingly been offered for morbidly obese patients prior to liver transplantation with the hope of improving both waitlist candidacy and post-transplant…
2020 American Transplant Congress
Taking Liver Transplant to “The Friendly Skies”: A Novel Pilot Program Using Commercial Flights and Ride-Sharing Apps to Minimize Dry-Run Expenses and Expand Potential Donors
G. J. McKenna, N. Onaca, H. Fernandez, E. Martinez, A. Gupta, A. Wall, J. Bayer, R. Ruiz, G. Testa
Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX
*Purpose: Growth in liver transplantation means using marginal/DCD donors, however these often fail to yield a suitable organ. Organ procurement can require travelling significant distances,…
2020 American Transplant Congress
Center Effects on Post-Transplant Outcomes in Liver Transplantation for Hilar Cholangiocarcinoma
S. Nagai¹, T. Kitajima¹, G. Sapisochin², D. Moonka¹, T. Hibi³
¹Henry Ford Hospital, Detroit, MI, ²University of Toronto, Toronto, ON, Canada, ³Kumamoto University, Kumamoto, Japan
*Purpose: Based on favorable outcomes reported by experienced centers, perihilar cholangiocarcinoma (Ph-CCA) has become an accepted indication for liver transplantation (LT). In the United States,…
2020 American Transplant Congress
Efficacy of Radiofrequency Ablation in the Treatment of Patients with Hepatocellular Carcinoma and Compensated Liver Disease: A Pathological Evaluation of Liver Explants
W. Alhamoudi¹, I. Salih², S. Yousif², M. Shawkat³, K. Bzeizi², A. Albenmousa², S. Alghamdi², M. Sturdevant², D. Broering², H. Alsuhaibani²
¹Medicine, King Saud University, Riyadh, Saudi Arabia, ²Liver Transplant, King Faisal Specialist Hospital, Riyadh, Saudi Arabia, ³Internal Medicine, Minia University, Minia, Egypt
*Purpose: Radiofrequency ablation (RFA) is a safe and effective treatment for patients with limited hepatocellular carcinoma (HCC). Ablative outcomes have been largely based on radiological…